Page last updated: 2024-08-16

propranolol and pyrimidinones

propranolol has been researched along with pyrimidinones in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's8 (66.67)18.2507
2000's3 (25.00)29.6817
2010's1 (8.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fukami, K; Takenawa, T1
Bormann, G; Hof, RP; Rüegg, UT; Salzmann, R; Zierhut, W1
Beckman, BS; Clejan, S; Dotson, R; Mallia, C; Vinson, D1
Beckman, B; Clejan, S; Corb, M; Ide, C; Walker, C; Wolf, E1
Cheng, JB; Cohan, VL; Eskra, JD; Griffiths, RJ; Pazoles, CJ; Pettipher, ER; Showell, HJ; Turner, CR; Watson, JW1
Pagano, RE; Salman, M1
Cheng, JB; Cohen, VL; Jayasinghe-Beck, R; Turner, CR; Watson, JW; Wright, KF1
Aye, NN; Hashimoto, K; Xue, Y; Yamada, C1
Groot, JA; Meijer, HP; Munnik, T; Oprins, JC; van der Burg, C1
Kosec, D; Leposavić, G; Plećas-Solarović, B; Rauski, A; Vidić-Danković, B1
Arakaki, T; Isomoto, S; Kawakami, A; Ono, K; Yamashita, S; Yano, K1

Other Studies

12 other study(ies) available for propranolol and pyrimidinones

ArticleYear
Phosphatidic acid that accumulates in platelet-derived growth factor-stimulated Balb/c 3T3 cells is a potential mitogenic signal.
    The Journal of biological chemistry, 1992, Jun-05, Volume: 267, Issue:16

    Topics: 3T3 Cells; Animals; Antibody Specificity; Chromatography, Thin Layer; Diglycerides; Enzyme-Linked Immunosorbent Assay; Mice; Mice, Inbred BALB C; Mitogens; Phosphatidic Acids; Phospholipase D; Platelet-Derived Growth Factor; Propranolol; Pyrimidinones; Signal Transduction; Thiazoles; Type C Phospholipases

1992
Pharmacological actions of SDZ 218-135, a novel positive inotropic agent.
    Cardiovascular drugs and therapy, 1994, Volume: 8, Issue:2

    Topics: Adenosine Triphosphate; Anesthesia; Animals; Arrhythmias, Cardiac; Cardiotonic Agents; Disease Models, Animal; Electrophysiology; Female; Guinea Pigs; Heart Atria; Hemodynamics; Isometric Contraction; Male; Myocardial Contraction; Myocardial Reperfusion Injury; Ovum; Papillary Muscles; Phosphodiesterase Inhibitors; Piperazines; Potassium; Propranolol; Pyrimidinones; Rabbits; Rats; Rats, Wistar; Sodium-Potassium-Exchanging ATPase; Triazoles

1994
Erythropoietin stimulates G-protein-coupled phospholipase D in haematopoietic target cells.
    The Biochemical journal, 1996, Mar-15, Volume: 314 ( Pt 3)

    Topics: Adenosine Triphosphate; Animals; Cell Line; Cell Membrane; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Diglycerides; DNA; Enzyme Activation; Enzyme Inhibitors; Erythropoietin; Ethanol; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Guanosine Diphosphate; Hematopoietic Stem Cells; Kinetics; Membranes; Mice; Phosphatidic Acids; Phospholipase D; Phospholipids; Phosphorylation; Propranolol; Pyrimidinones; Thiazoles; Thionucleotides; Thymidine

1996
Electromagnetic field induced changes in lipid second messengers.
    Journal of lipid mediators and cell signalling, 1996, Volume: 13, Issue:3

    Topics: Cell Line; Choline; Diglycerides; Electromagnetic Fields; Enzyme Inhibitors; Ethanol; Flow Cytometry; Humans; Lipids; Molecular Structure; Phosphatidate Phosphatase; Phosphatidic Acids; Phospholipase D; Phospholipids; Phosphorylcholine; Propranolol; Pyrimidinones; Second Messenger Systems; Thiazoles; Time Factors; Tritium

1996
The phosphodiesterase type 4 (PDE4) inhibitor CP-80,633 elevates plasma cyclic AMP levels and decreases tumor necrosis factor-alpha (TNFalpha) production in mice: effect of adrenalectomy.
    The Journal of pharmacology and experimental therapeutics, 1997, Volume: 280, Issue:2

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adrenalectomy; Animals; Cyclic AMP; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Dipyridamole; Epinephrine; Humans; Kinetics; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; Monocytes; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piroxicam; Propranolol; Purinones; Pyrimidinones; Thromboxane B2; Time Factors; Tumor Necrosis Factor-alpha; Vinca Alkaloids

1997
Use of a fluorescent analog of CDP-DAG in human skin fibroblasts: characterization of metabolism, distribution, and application to studies of phosphatidylinositol turnover.
    Journal of lipid research, 1997, Volume: 38, Issue:3

    Topics: 4-Chloro-7-nitrobenzofurazan; Cells, Cultured; Chromatography, Thin Layer; Cyclohexanones; Cytidine Diphosphate Diglycerides; Enzyme Inhibitors; Fibroblasts; Fluorescent Dyes; Humans; Interleukin-1; Lipoprotein Lipase; Membrane Lipids; Microscopy, Fluorescence; Oleic Acid; Palmitic Acid; Phosphatidic Acids; Phosphatidylcholines; Phosphatidylinositols; Platelet-Derived Growth Factor; Propranolol; Pyrimidinones; Thiazoles

1997
Differential in vivo and in vitro bronchorelaxant activities of CP-80,633, a selective phosphodiesterase 4 inhibitor.
    Canadian journal of physiology and pharmacology, 1997, Volume: 75, Issue:8

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adrenergic beta-Antagonists; Animals; Bronchodilator Agents; Catecholamines; Cyclic Nucleotide Phosphodiesterases, Type 4; Dose-Response Relationship, Drug; Guinea Pigs; Male; Muscle Relaxation; Muscle, Smooth; Phosphodiesterase Inhibitors; Propranolol; Pyridazines; Pyrimidinones; Pyrrolidinones; Rolipram; Trachea

1997
MS-551 and KCB-328, two class III drugs aggravated adrenaline-induced arrhythmias.
    British journal of pharmacology, 1998, Volume: 124, Issue:8

    Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Dogs; Electrocardiography; Epinephrine; Female; Heart Rate; Hemodynamics; In Vitro Techniques; Male; Phenethylamines; Propranolol; Pyrimidinones; Sulfonamides

1998
PLD pathway involved in carbachol-induced Cl- secretion: possible role of TNF-alpha.
    American journal of physiology. Cell physiology, 2001, Volume: 280, Issue:4

    Topics: 1-Butanol; Adrenergic beta-Antagonists; Carbachol; Carcinogens; Chlorides; Cholinergic Agonists; Chromatography, Thin Layer; Diacylglycerol Kinase; Diglycerides; Dose-Response Relationship, Drug; Enzyme Inhibitors; HT29 Cells; Humans; Indoles; Intestinal Mucosa; Maleimides; Phorbol Esters; Phospholipase D; Propranolol; Protein Kinase C; Pyrimidinones; Receptors, Muscarinic; Signal Transduction; Thiazoles; Tumor Necrosis Factor-alpha

2001
Effects of beta-adrenoceptor blockade on the phenotypic characteristics of thymocytes and peripheral blood lymphocytes.
    The International journal of neuroscience, 2003, Volume: 113, Issue:12

    Topics: Adrenergic beta-Antagonists; Animals; Apoptosis; CD4 Antigens; CD4-Positive T-Lymphocytes; CD8 Antigens; CD8-Positive T-Lymphocytes; Cell Count; Cell Differentiation; Cells, Cultured; Flow Cytometry; Lymphocyte Activation; Male; Organ Size; Phenotype; Propidium; Propranolol; Pyrimidinones; Rats; Rats, Inbred Strains; Receptors, Antigen, T-Cell; Receptors, Antigen, T-Cell, alpha-beta; Receptors, Interleukin-2; T-Lymphocyte Subsets; T-Lymphocytes; Thymus Gland

2003
Effects of antiarrhythmic drugs on apoptotic pathways in H9c2 cardiac cells.
    Journal of pharmacological sciences, 2006, Volume: 101, Issue:4

    Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Apoptosis; Caspases; Cell Line; Clone Cells; Diploidy; DNA Fragmentation; Dose-Response Relationship, Drug; Lidocaine; Membrane Potentials; Mitochondrial Membranes; Propranolol; Pyrimidinones; Signal Transduction; Time Factors; Verapamil

2006
Mek Inhibitor Reverses Hypertrophic Cardiomyopathy in RIT1 Mutated Noonan Syndrome: For the first time, hypertrophic cardiomyopathy was reversed in Noonan syndrome associated with a RIT1 mutation.
    American journal of medical genetics. Part A, 2019, Volume: 179, Issue:8

    Topics: Anti-Arrhythmia Agents; Antineoplastic Agents; Cardiomyopathy, Hypertrophic; Cardiovascular Agents; Drug Repositioning; Echocardiography; Gene Expression Regulation; Heart Valves; Heterozygote; Humans; Infant; MAP Kinase Kinase 1; Mutation; Natriuretic Peptide, Brain; Noonan Syndrome; Peptide Fragments; Propranolol; Protein Kinase Inhibitors; Pyridones; Pyrimidinones; ras Proteins; Signal Transduction; Treatment Outcome

2019